Joost Vermaat, Pim Mutsaers, Sébastien Anguille, Maria Kuipers, Evelyne Willems, Tim Dekker, Peter Vandenberghe, Guillaume Dachy, Caron Jacobson, Michael Bishop, Martin Dreyling, Andreas Klein, Jon Arnason, Stavros Milatos, Harini Kothari, Daniela Buglio, Sandra Blum, Leonardo Chicaybam, Eva Santermans, Omotayo Fasan, Marie José Kersten. "High complete response rates, low dropout rate, and low-grade toxicities in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) receiving GLPG5101, a fresh, early memory-enriched CAR T-cell therapy with a 7-day vein-to-vein time: Results from the ATALANTA-1 DLBCL cohort." Blood, 2025. doi:10.1182/blood-2025-5940